6Via J, MarcosA. MarcoF, et al. In vitro antimicrobial Production of beta-lactamases, aminoglycoside madifying enzymes and chloramphenicol aceyltransferase and susceptibility of clinical isolates of acintobacter baumanni. Antimierob Agents Chemother, 2002, 37 : 138.
7Mandell LA, Bartlett JG, DoweU SF, et al . Update of practice guidelines for management of community-acquired pneumonia in immunoeompe-tentaduhs . Clin InfectDis,2003 ,37 :1405-33.
8Canto ittee for The Japanese Respiratory Society guidelines for the management of respiratory infections Guidelines for the management of community acquired pneumonin in adults revised edition[ J]. Respirology 2006 ( Suppl3 ) : S79 - 133.
9Fine M J, Auble TE,Yealy DM,et al. A prediction rule to identify low-risk patients with community acquired pneumonia. N Engl J Med, 1997, 336:243-250.
10Lim WS,Van der Eerden MM, Laing R,et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax, 2003,58: 377 -382.
2Welte T. Community-acquired pneumonia: a disease of the elderly[J]. Z Gerontol Geriatr, 2011, 44(4): 221-228.
3Marrie T J. Community-acquired pneumonia in the elderly [J]. Clin Infect Dis, 2000, 31(4): 1066-1078.
4Torres A, E1-Ebiary M, Riquelme R, et al. Community- acquired pneumonia in the elderly[J]. Semin Respir Infect, 1999, 14 (2):173-183.
5Venkatesan P, Gladman J, Macfarlane J T, et al. A hospital study of community acquired pneumonia in the elderly[J]. Thorax, 1990, 45(4): 254-258.
6Fernfindez-Sab6 N, Carratal J, Ros6n B, et al. Community- acquired pneumonia in very elderly patients: causative or- ganisms, clinical characteristics, and outcomes [J]. Medicine (Baltimore), 2003, 82(3): 159-169.
